doi: 10.1111/j.1399-3054.2006.00872.x We investigated the distribution of Frankia genotypes with respect to three altitudinal zones in the Sikkim Himalayas. The study was carried out for 90 Alnus nepalensis trees at nine different locations from three altitudes from the east and north districts of Sikkim, India. We used a PCR-based technique to amplify the internally transcribed spacer (ITS) region of the rrn operon using two primers specific for the distal part of 16S ribosomal RNA (rRNA), ITS and proximal part of 23S rRNA genes of Frankia. The PCR products were digested with the restriction enzyme RsaI to generate amplified recombinant DNA restriction analysis (ARDRA) patterns. Frankia genotypes were categorized on the basis of 17 different ARDRA patterns. Nucleotide sequences of some representative amplicons were also obtained. Rhizosphere soil samples associated with the 90 trees were collected and analysed for eight different soil properties. In general, soil properties did not differ by site or altitude, and did not correlate with Frankia genotypes. Frankia community composition was strongly affected by altitude and to a lesser extent by site
Molecular diversity of Frankia was assessed directly from the root nodules of Hippophae salicifolia naturally occurring in North Sikkim. Amplicon restriction patterns (ARPs) were developed by digesting 16S-ITS-23S amplicons with RsaI. Three ARPs were detected, showing diversity among strains of Frankia that nodulate Hippophae. This was confi rmed by sequencing one amplicon each for the three ARPs. Therefore, ARP can be used as a tool for screening amplicons for nucleotide sequencing.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.